Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Relevant to copper peptide, extracellular matrix and collagen-related research
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
doi:10.1017/s135561770410711x Bienvenu OJ, Friedman LA, Colantuoni E, et al
Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months
US$ 21.15
US$ 21.30
US$ 25.58
US$ 26.21
US$ 28.91
US$ 20.87
US$ 22.08
US$ 22.45
US$ 23.78
